Good morning, everyone, and how are you today? We are just fine, thank you, especially since a bright, shiny sun and cool breeze are enveloping the Pharmalot campus. Our short people are getting ready for another busy day and our official mascots are snoozing about. All of which is to say that we are free to focus on the matters at hand. On that note, the time has come to fire up the coffee kettle and forage for interesting items. Meanwhile, we hope your journey goes well today and that you conquer the world. And as always, do keep in touch …
The EpiPen shortage could turn into a crisis as the back-to-school season unfolds, MarketWatch points out. Parents say it is increasingly difficult to find the allergy-reaction device. “We are concerned that the shortage has not gone away,” said Jen Madsen of the Food Allergy Research and Education advocacy group. “We were certainly hoping it would be fixed by now, and it’s not, which is unfortunate.” The device is made for Mylan (MYL) by Pfizer (PFE), which has ongoing manufacturing problems at a plant.
About the Author Reprints
